EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Increased mortality in chronic hypoparathyroidism: a nationwide cohort study in Sweden

Wafa Kamal iD, Ylva Trolle Lagerros, Michael Mannstadt, Tim Spelman, Olle Kämpe, Sigridur Björnsdottir

Endocrine Connections · 01.07.2026 · 15 (7)

DOI: 10.1530/ec-25-0450 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Endocrine Connections, online erschienen am 17.06.2026. Verfasst von Wafa Kamal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital , Stockholm, Sweden. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Previous studies on mortality outcomes in patients with chronic hypoparathyroidism have reported inconsistent results.

Objective

To assess all-cause and cause-specific mortality and estimate the prevalence of chronic hypoparathyroidism in Sweden.

Methods

Chronic hypoparathyroidism was defined as the combination of ICD-10 diagnoses and long-term dispensations of active vitamin D. Nationwide diagnostic codes, drug dispensation, and mortality data were obtained from the National Patient Register, Prescribed Drugs Register, Cause of Death Register, and the Total Population Register. Mortality was compared between groups using Cox proportional hazards models, adjusting for age and baseline comorbidities.

Results

We identified 1,982 individuals with chronic hypoparathyroidism between 1997 and 2018, yielding a minimum prevalence of 19.4 per 100,000 inhabitants. We randomly selected 19,820 controls matched by age, sex, and county of residence. After excluding individuals with baseline thyroid cancer and their controls, 1,825 patients and 17,922 controls remained. Patients had higher all-cause mortality than controls (HR: 1.55; 95% CI: 1.40–1.72). Mortality was higher in patients with nonsurgical (HR: 2.16, 95% CI: 1.76–2.65) than postsurgical hypoparathyroidism (HR: 1.39, 95% CI: 1.23–1.58). The strongest associations were observed for endocrine, nutritional, and metabolic disorders (HR: 6.46, 95% CI: 2.43–17.21), followed by infectious diseases (HR: 3.53, 95% CI: 2.07–6.04), genitourinary diseases (HR: 2.40, 95% CI: 1.33–4.33), respiratory diseases (HR: 1.67, 95% CI: 1.23–2.28), and circulatory diseases (HR: 1.47, 95% CI: 1.23–1.77).

Conclusion

Patients with chronic hypoparathyroidism have an elevated risk of all-cause mortality, particularly those with nonsurgical disease. These findings highlight the clinical burden of the disease.

Schlagwörter

Stichwörter der Autor:innen

Swedenepidemiologyhypoparathyroidismmortalityprevalence

Autor:innen und Institutionen

  • Department of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital , Stockholm, Sweden.
  • Department of Medicine, Solna, Karolinska Institutet , Stockholm, Sweden.
  • Department of Medicine, Huddinge, Karolinska Institutet , Stockholm, Sweden.
  • Endocrine Unit, Massachusetts General Hospital and Harvard Medical School , Boston, USA.
  • Department of Clinical Neuroscience, Karolinska Institutet , Stockholm, Sweden.
  • Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm, Sweden.

ORCID-Profile: Wafa Kamal

Zitieren

APA

Kamal, W., Lagerros, Y. T., Mannstadt, M., Spelman, T., Kämpe, O., & Björnsdottir, S. (2026). Increased mortality in chronic hypoparathyroidism: a nationwide cohort study in Sweden. Endocrine Connections, 15(7). https://doi.org/10.1530/ec-25-0450

Vancouver

Kamal W, Lagerros YT, Mannstadt M, Spelman T, Kämpe O, Björnsdottir S. Increased mortality in chronic hypoparathyroidism: a nationwide cohort study in Sweden. Endocrine Connections. 2026;15(7). doi:10.1530/ec-25-0450

BibTeX
@article{Kamal2026,
  author = {Kamal, Wafa and Lagerros, Ylva Trolle and Mannstadt, Michael and Spelman, Tim and Kämpe, Olle and Björnsdottir, Sigridur},
  title = {Increased mortality in chronic hypoparathyroidism: a nationwide cohort study in Sweden},
  journal = {Endocrine Connections},
  year = {2026},
  volume = {15},
  number = {7},
  doi = {10.1530/ec-25-0450}
}
Kostenlos starten →